Soleus Capital Management, L.P. — 13F Holdings

2026 Q3  ·  124 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Soleus Capital Management, L.P. maintained a portfolio of 124 distinct positions. The most significant new addition was ZAI LAB LTD, now representing 1.44% of the total fund value. They heavily accumulated shares in INSULET CORP, increasing the position by 64.6%. Conversely, Soleus Capital Management, L.P. completely exited their position in INDIVIOR PHARMACEUTICALS INC.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
124
Quarter
2026 Q3
Top Holding
KRYS (13.5%)
Top 10 Concentration
53.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 124

Soleus Capital Management, L.P. Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
KRYS
KRYSTAL BIOTECH...
Healthcare 13.47% 12.03% #1
Prev: #1
8.5
—
200,446 21.3%
P
S
1,139,700 $379,018,632 2020 Q4 13F Filing 2026-09-30 2026-11-16
PODD
INSULET CORP
Healthcare 8.01% 5.50% #2 2
Prev: #4
7.7
—
677,500 64.6%
P
S
1,726,500 $225,256,455 2020 Q2 13F Filing 2026-09-30 2026-11-16
NVCR
NOVOCURE LTD
Healthcare 5.34% 5.18% #3 2
Prev: #5
3.6
—
-487,625 -4.9%
P
S
9,425,776 $150,341,127 2020 Q1 13F Filing 2026-09-30 2026-11-16
TGTX
TG THERAPEUTICS...
Healthcare 5.07% 5.54% #4 1
Prev: #3
3.0
—
-371,727 -12.7%
P
S
2,556,168 $142,583,051 2022 Q4 13F Filing 2026-09-30 2026-11-16
UTHR
UNITED THERAPEU...
Healthcare 4.99% 4.21% #5 1
Prev: #6
4.5
—
33,413 14.8%
P
S
259,000 $140,349,510 2021 Q3 13F Filing 2026-09-30 2026-11-16
CELC
CELCUITY INC
Healthcare 4.76% 6.14% #6 4
Prev: #2
2.4
—
-21,558 -1.3%
P
S
1,682,760 $133,813,075 2021 Q2 13F Filing 2026-09-30 2026-11-16
RIGL
RIGEL PHARMACEU...
Healthcare 3.16% 2.49% #7 1
Prev: #8
2.3
—
no change no change
P
S
1,843,504 $88,764,718 2024 Q2 13F Filing 2026-09-30 2026-11-16
INSP
INSPIRE MED SYS...
Healthcare 2.98% 2.97% #8 1
Prev: #7
1.2
—
-724,608 -37.5%
P
S
1,206,828 $83,705,590 2019 Q4 13F Filing 2026-09-30 2026-11-16
ERAS
ERASCA INC
Healthcare 2.66% 1.70% #9 6
Prev: #15
4.1
—
2,412,000 89.3%
P
S
5,112,000 $74,941,920 2024 Q2 13F Filing 2026-09-30 2026-11-16
BBNX
BETA BIONICS IN...
Healthcare 2.53% 2.37% #10
Prev: #10
1.5
—
-650,000 -14.8%
P
S
3,743,714 $71,055,692 2025 Q1 13F Filing 2026-09-30 2026-11-16
ANIP
ANI PHARMACEUTI...
Healthcare 2.52% 2.48% #11 2
Prev: #9
3.0
—
107,740 12.4%
P
S
975,500 $70,870,075 2024 Q3 13F Filing 2026-09-30 2026-11-16
VCEL
VERICEL CORP
Healthcare 2.22% 2.24% #12 1
Prev: #11
2.9
—
94,907 6.5%
P
S
1,554,059 $62,379,928 2019 Q4 13F Filing 2026-09-30 2026-11-16
GERN
GERON CORP
Healthcare 2.04% 1.89% #13
Prev: #13
2.8
—
3,960,000 9.3%
P
S
46,768,659 $57,525,451 2025 Q1 13F Filing 2026-09-30 2026-11-16
PBLS
PARABILIS MEDIC...
Healthcare 1.93% 1.38% #14 5
Prev: #19
2.8
—
219,442 15.0%
P
S
1,684,512 $54,392,892 2026 Q2 13F Filing 2026-09-30 2026-11-16
ARGX
ARGENX SE
Healthcare 1.68% 0.64% #15 26
Prev: #41
3.7
—
29,395 147.3%
P
S
49,350 $47,322,209 2019 Q4 13F Filing 2026-09-30 2026-11-16
AXGN
AXOGEN INC
Healthcare 1.61% 0.09% #16 66
Prev: #82
3.6
—
1,023,964 1795.3%
P
S
1,081,000 $45,315,520 2019 Q4 13F Filing 2026-09-30 2026-11-16
NPCE
NEUROPACE INC
Healthcare 1.57% 1.59% #17 1
Prev: #16
2.6
—
306,878 10.5%
P
S
3,218,000 $44,279,680 2021 Q2 13F Filing 2026-09-30 2026-11-16
EOLS
EVOLUS INC
Healthcare 1.45% 0.20% #18 56
Prev: #74
3.6
—
4,267,572 518.9%
P
S
5,090,000 $40,720,000 2021 Q2 13F Filing 2026-09-30 2026-11-16
ZLAB
ZAI LAB LTD
Healthcare 1.44% — #19
Prev: #—
4.1
—
1,543,000 —
NEW
1,543,000 $40,642,620 2026 Q3 13F Filing 2026-09-30 2026-11-16
PGNY
PROGYNY INC
Healthcare 1.42% 1.59% #20 3
Prev: #17
1.1
—
-20,000 -1.2%
P
S
1,582,000 $39,850,580 2026 Q1 13F Filing 2026-09-30 2026-11-16
TRVI
TREVI THERAPEUT...
Healthcare 1.39% 0.76% #21 17
Prev: #38
3.6
—
1,548,109 131.2%
P
S
2,727,727 $39,061,051 2025 Q2 13F Filing 2026-09-30 2026-11-16
NVCT
NUVECTIS PHARMA...
Healthcare 1.28% 0.63% #22 20
Prev: #42
3.5
—
710,658 71.1%
P
S
1,710,658 $36,129,097 2026 Q2 13F Filing 2026-09-30 2026-11-16
EDAP
EDAP TMS S A
Healthcare 1.16% 1.30% #23 3
Prev: #20
1.5
—
no change no change
P
S
7,309,254 $32,672,365 2021 Q1 13F Filing 2026-09-30 2026-11-16
AVLN
AVALYN PHARMACE...
Healthcare 1.03% 0.48% #24 26
Prev: #50
3.4
—
600,000 143.2%
P
S
1,019,000 $29,031,310 2026 Q2 13F Filing 2026-09-30 2026-11-16
KOD
KODIAK SCIENCES...
Healthcare 0.97% — #25
Prev: #—
3.9
—
286,966 —
NEW
286,966 $27,204,377 2025 Q3 13F Filing 2026-09-30 2026-11-16
SLN
SILENCE THERAPE...
Healthcare 0.93% 0.24% #26 42
Prev: #68
3.4
—
1,755,700 278.7%
P
S
2,385,700 $26,075,701 2024 Q3 13F Filing 2026-09-30 2026-11-16
IKT
INHIBIKASE THER...
Healthcare 0.82% 0.76% #27 10
Prev: #37
0.8
—
350,000 3.2%
P
S
11,225,000 $23,067,375 2024 Q4 13F Filing 2026-09-30 2026-11-16
RCUS
ARCUS BIOSCIENC...
Healthcare 0.79% 1.24% #28 6
Prev: #22
0.3
—
-306,738 -26.2%
P
S
862,000 $22,265,460 2025 Q4 13F Filing 2026-09-30 2026-11-16
LEGN
LEGEND BIOTECH ...
Healthcare 0.77% 1.20% #29 4
Prev: #25
0.8
—
-119,450 -9.9%
P
S
1,085,550 $21,591,590 2026 Q2 13F Filing 2026-09-30 2026-11-16
NRIX
NURIX THERAPEUT...
Healthcare 0.75% 1.22% #30 6
Prev: #24
0.3
—
-573,000 -39.1%
P
S
892,163 $21,153,185 2021 Q3 13F Filing 2026-09-30 2026-11-16
INBX
INHIBRX BIOSCIE...
Healthcare 0.75% — #31
Prev: #—
3.8
—
210,000 —
NEW
210,000 $21,016,800 2020 Q3 13F Filing 2026-09-30 2026-11-16
ANL
ADLAI NORTYE GR...
Healthcare 0.72% 0.16% #32 43
Prev: #75
3.3
—
866,832 213.8%
P
S
1,272,355 $20,357,680 2026 Q2 13F Filing 2026-09-30 2026-11-16
PALI
PALISADE BIO IN...
Healthcare 0.72% 0.94% #33 2
Prev: #31
2.3
—
1,932,467 14.8%
P
S
14,996,154 $20,244,808 2026 Q2 13F Filing 2026-09-30 2026-11-16
ALKS
ALKERMES PLC
Healthcare 0.72% 1.86% #34 20
Prev: #14
0.3
—
-531,546 -51.6%
P
S
497,706 $20,167,047 2023 Q1 13F Filing 2026-09-30 2026-11-16
TNGX
TANGO THERAPEUT...
Healthcare 0.71% 0.76% #35 1
Prev: #36
2.3
—
93,297 13.2%
P
S
802,297 $20,017,310 2023 Q2 13F Filing 2026-09-30 2026-11-16
BDSX
BIODESIX INC
Healthcare 0.71% 0.46% #36 15
Prev: #51
2.3
—
81,877 14.0%
P
S
667,835 $19,921,518 2024 Q2 13F Filing 2026-09-30 2026-11-16
PHVS
PHARVARIS N V
Healthcare 0.68% 0.87% #37 5
Prev: #32
0.8
—
-126,907 -17.4%
P
S
604,000 $19,158,880 2022 Q4 13F Filing 2026-09-30 2026-11-16
INSM
INSMED INC
Healthcare 0.60% 0.33% #38 19
Prev: #57
3.2
—
56,750 62.9%
P
S
147,000 $16,778,580 2023 Q3 13F Filing 2026-09-30 2026-11-16
PRAX
PRAXIS PRECISIO...
Healthcare 0.59% 2.05% #39 27
Prev: #12
0.2
—
-121,002 -68.2%
P
S
56,515 $16,458,863 2024 Q1 13F Filing 2026-09-30 2026-11-16
JBIO
JADE BIOSCIENCE...
Healthcare 0.58% 1.19% #40 14
Prev: #26
0.2
—
-379,762 -24.5%
P
S
1,170,928 $16,451,538 2025 Q2 13F Filing 2026-09-30 2026-11-16
KNSA
KINIKSA PHARMAC...
Healthcare 0.58% 0.54% #41 7
Prev: #48
0.7
—
-27,395 -11.1%
P
S
218,958 $16,336,456 2024 Q2 13F Filing 2026-09-30 2026-11-16
CNMD
CONMED CORP
Healthcare 0.57% — #42
Prev: #—
3.7
—
347,333 —
NEW
347,333 $16,057,205 2026 Q3 13F Filing 2026-09-30 2026-11-16
ETON
ETON PHARMACEUT...
Healthcare 0.56% — #43
Prev: #—
3.7
—
308,101 —
NEW
308,101 $15,864,120 2025 Q2 13F Filing 2026-09-30 2026-11-16
KIDS
ORTHOPEDIATRICS...
Healthcare 0.56% 0.48% #44 5
Prev: #49
0.7
—
-21,946 -3.0%
P
S
710,198 $15,816,109 2022 Q4 13F Filing 2026-09-30 2026-11-16
ORGO
ORGANOGENESIS H...
Healthcare 0.55% 0.85% #45 12
Prev: #33
2.2
—
1,160,000 11.4%
P
S
11,300,951 $15,482,303 2021 Q3 13F Filing 2026-09-30 2026-11-16
GRAL
GRAIL INC
Healthcare 0.54% — #46
Prev: #—
3.7
—
108,500 —
NEW
108,500 $15,203,020 2025 Q4 13F Filing 2026-09-30 2026-11-16
MBX
MBX BIOSCIENCES...
Healthcare 0.54% 0.98% #47 17
Prev: #30
0.2
—
-256,382 -49.8%
P
S
258,897 $15,176,542 2025 Q3 13F Filing 2026-09-30 2026-11-16
EWTX
EDGEWISE THERAP...
Healthcare 0.48% 0.63% #48 4
Prev: #44
0.2
—
-120,902 -26.8%
P
S
329,987 $13,397,472 2021 Q1 13F Filing 2026-09-30 2026-11-16
AMRX
AMNEAL PHARMACE...
Healthcare 0.47% — #49
Prev: #—
3.7
—
658,000 —
NEW
658,000 $13,252,120 2026 Q3 13F Filing 2026-09-30 2026-11-16
PRLD
PRELUDE THERAPE...
Healthcare 0.47% 0.62% #50 5
Prev: #45
1.2
—
no change no change
P
S
3,378,378 $13,209,458 2026 Q2 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 124 holdings

Unlock Full Soleus Capital Management, L.P. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →